Cysteine-containing fusion tag for site-specific conjugation of therapeutic and imaging agents to targeting proteins

Methods in Molecular Biology

Volumn 494, Issue , 2008, Pages 275-294

  Backer, Marina V ^a   Levashova, Zoia ^b   Levenson, Richard ^c   Blankenberg, Francis G ^b   Backer, Joseph M ^a  

^a SIBTECH INC   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Cambridge Research & Instrumentation Inc   (United States)

Author keywords

Cysteine containing tag; Dendrimers; Liposomes; Site specific conjugation; Targeted drug delivery; Targeted imaging

Indexed keywords

EID: 84934442275     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-419-3_16     Document Type: Article

References (15)

1. Backer, M. V., Gaynutdinov, T. I., Patel V., et al. (2005) Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature. Mol. Cancer. Ther. 4, 1423-1429.
2. 99mTc- HYNIC-VEGF. Eur. J. Nucl. Med. Mol. Imag. 33, 841-848.
3. Thirumamagal, B. T. S., Zhao, X. B., Bandyopadhyaya, A. K., et al. (2006) Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT). Bioconjugate Chem. 17, 1141-1150.
4. Backer, M. V., Patel, V., Jehning, B. T., Claffey, K., and Backer, J. M. (2006) Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag. Biomaterials 27, 5452-5458.
5. Backer, M.V. Patel, V., Jehning, B., and Backer, J. M. (2006) Self-assembled "dock and lock" system for linking payloads to targeting proteins. Bioconjugate Chem. 17, 912-919.
6. Backer, M. V., Levashova, Z., Patel, V., et al. (2007) Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF driven probes. Nature Med. 13, 504-509.
7. Backer, M. V., Patel, V., Jehning, B. T., Claffey, K., Karginov, V. A., and Backer, J. M. (2007) Inhibition of anthrax protective antigen outside and inside the cell. Antimicrob. Agent. Chemother. 51, 245-251.
8. Torchilin, V. P. (2005) Recent advances with liposomes as pharmaceutical carriers. Nature Rev. Drug Discov. 4, 145-160.
9. Allen, T. M., and Martin, F. J. (2004) Advantages of liposomal delivery systems for anthracyclines. Semin. Oncol. 31, 5-15.
10. Allen, T. M., Sapra, P., Moase, E., Moreira, J., and Iden, D. (2002) Adventures in targeting. J. Liposome Res. 12, 5-12.
11. Sapra, P., Tyagi, P., and Allen, T. M. (2005) Ligand-targeted liposomes for cancer treatment. Curr. Drug Deliv. 2, 369-381.
12. Ntziachristos, V. (2006) Fluorescence molecular imaging. Annu. Rev. Biomed. Eng. 8, 1-33.
13. Graves, E. E., Weissleder, R., and Ntziachristos, V. (2004) Fluorescence molecular imaging of small animal tumor models. Curr. Mol. Med. 4, 419-430.
14. Tait, J. F., Brown, D. S., Gibson, D. F., Blankenberg, F. G., and Strauss, H. W. (2000) Development and characterization of annexin V mutants with endogenous chelation sites for 99mTc. Bioconjug. Chem. 11, 918-925.
15. Levashova, Z., Backer, M.V., Backer, J.M., Blankenberg, F.G. (2008)Direct labeling of Cys-tag in scVEGF with technetium 99m. Bioconjugate Chem. 19, 1049-1054.